Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Ladanyi
    Ladanyi
  2. Arcila
    Arcila
  3. Nafa
    Nafa
  4. Berger
    Berger
  5. Deng
    Deng
  6. D'Angelica
    D'Angelica
  7. Jarnagin
    Jarnagin
  8. Kingham
    Kingham
  9. Shuman
    Shuman
  10. Balachandran
    Balachandran

Groups

  1. Human Oncology and Pathogenesis Program (243)
  2. GSK Faculty (242)
  3. Tow Center for Developmental Oncology (TCDO) (138)
  4. Department of Medicine (128)
  5. Solid Tumor Oncology Division (84)
  6. Sloan Kettering Institute Postdocs (62)
  7. Surgery (61)
  8. Center for Pancreatic Cancer Research (55)
  9. Epidemiology and Biostatistics (39)
  10. Population Sciences Research Program (39)
Search Within
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (125)
  2. Journal Article (109)
  3. Review (7)
  4. Correspondence (1)
  5. Editorial (1)
Groups
  1. Human Oncology and Pathogenesis Program (243)
  2. GSK Faculty (242)
  3. Tow Center for Developmental Oncology (TCDO) (138)
  4. Department of Medicine (128)
  5. Solid Tumor Oncology Division (84)
  6. Sloan Kettering Institute Postdocs (62)

More Groups

People
  1. Marc Ladanyi (116)
  2. Maria Arcila (61)
  3. Ahmet Zehir (43)
  4. Khedoudja Nafa (42)
  5. Michael Berger (42)
  6. Vinod Balachandran (30)

More People

Years
  1. 2024 (2)
  2. 2023 (12)
  3. 2022 (12)
  4. 2021 (15)
  5. 2020 (21)
  6. 2019 (14)

More Years

Publications
  1. Journal of Molecular Diagnostics (104)
  2. Journal of Investigative Dermatology (27)
  3. American Journal of Pathology (17)
  4. Journal of the American College of Surgeons (17)
  5. European Urology (15)
  6. HPB (13)

More Publications

Results (243)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Timing of complications and failure to rescue after hepatectomy: A single-institution analysis of 28 years of hepatic operations
    Meeting Abstract

    Saadat, L. V.; Goldman, D. A.; Gonen, M.; Soares, K.; Wei, A. C.; Balachandran, V. P.; Kingham, T. P.; Drebin, J. A.; Jarnagin, W. R.; D'Angelica, M. I.
    Journal of the American College of Surgeons (2020)

    Fulltext@MSK | Save
  • Survival in patients with intrahepatic cholangiocarcinoma and positive lymph nodes: No benefit of resection over hepatic arterial infusion chemotherapy
    Meeting Abstract

    Jolissaint, J. S.; Soares, K.; Seier, K.; Gonen, M.; Balachandran, V.; Kingham, T. P.; D'Angelica, M.; Drebin, J. A.; Kemeny, N.; Jarnagin, W. R.
    Journal of the American College of Surgeons (2020)

    Fulltext@MSK | Save
  • RAS/MAPK pathway driver alterations are significantly associated with oncogenic KIT mutations in germ-cell tumors
    Journal Article

    Mata, D. A.; Yang, S. R.; Ferguson, D. C.; Liu, Y.; Sharma, R.; Benhamida, J. K.; Al-Ahmadie, H. A.; Chakravarty, D.; Solit, D. B.; Tickoo, S. K.; more...
    Urology (2020)

    Fulltext@MSK | Save
  • The impact of hepatic arterial infusion pump chemotherapy on hepatic recurrences and survival in patients with resected colorectal liver metastases
    Journal Article

    Buisman, F. E.; Galjart, B.; van der Stok, E. P.; Kemeny, N. E.; Balachandran, V. P.; Boerner, T.; Cercek, A.; Grünhagen, D. J.; Jarnagin, W. R.; Kingham, T. P.; more...
    HPB (2020)

    Fulltext@MSK | Save
  • Pan-cancer analysis of CDK12 alterations identifies a subset of prostate cancers with distinct genomic and clinical characteristics
    Journal Article

    Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H. I.; Kantoff, P. W.; Gopalan, A.; more...
    European Urology (2020)

    Fulltext@MSK | Save
  • Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): A double-blind, randomised, placebo-controlled, phase 3 trial
    Journal Article

    Blay, J. Y.; Serrano, C.; Heinrich, M. C.; Zalcberg, J.; Bauer, S.; Gelderblom, H.; Schöffski, P.; Jones, R. L.; Attia, S.; D'Amato, G.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Histopathological growth patterns and positive margins after resection of colorectal liver metastases
    Journal Article

    Nierop, P. M. H.; Höppener, D. J.; van der Stok, E. P.; Galjart, B.; Buisman, F. E.; Balachandran, V. P.; Jarnagin, W. R.; Kingham, T. P.; Allen, P. J.; Shia, J.; more...
    HPB (2020)

    Fulltext@MSK | Save
  • Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: A single-centre, single-arm, phase 2 trial
    Journal Article

    Taylor, J.; Mi, X.; Penson, A. V.; Paffenholz, S. V.; Alvarez, K.; Sigler, A.; Chung, S. S.; Rampal, R. K.; Park, J. H.; Stein, E. M.; more...
    The Lancet Haematology (2020)

    Fulltext@MSK | Save
  • First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: An open-label, single-arm, phase 2 trial
    Journal Article

    Janjigian, Y. Y.; Maron, S. B.; Chatila, W. K.; Millang, B.; Chavan, S. S.; Alterman, C.; Chou, J. F.; Segal, M. F.; Simmons, M. Z.; Momtaz, P.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Larotrectinib in patients with TRK fusion-positive solid tumours: A pooled analysis of three phase 1/2 clinical trials
    Journal Article

    Hong, D. S.; DuBois, S. G.; Kummar, S.; Farago, A. F.; Albert, C. M.; Rohrberg, K. S.; van Tilburg, C. M.; Nagasubramanian, R.; Berlin, J. D.; Federman, N.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save